TABLE 1.
Clinicodemographic characteristics of the cohort.
| Characteristic | Total cohort, N = 4366 |
|---|---|
| Participants per site, n | Barts 1016 |
| Belfast 196 | |
| Bristol 99 | |
| Cardiff 802 | |
| Leeds 1169 | |
| Newport 263 | |
| Nottingham 105 | |
| Southampton 100 | |
| Stoke 94 | |
| Swansea 230 | |
| UCL Hospital 100 | |
| University Hospital Coventry 94 | |
| Ulster 98 | |
| Sex, female, n (%) | 3152 (72%) |
| Age at first DMT, years, mean (SD) | 37.6 (10.2) |
| Disease duration at first DMT, years, mean (SD) | 6.3 (6.6) |
| Number of DMTs received at last follow‐up, mean, (SD) | 1.6 (0.9) |
Abbreviations: DMT, disease‐modifying therapy; UCL, University College London.